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A 56-year-old woman, who underwent cardiac surgery 3 months previously, presented to the emergency 
room with pulmonary artery rupture due to the cytotoxic effects of BioGlue (CryoLife Inc., Kennesaw, GA, 
USA). She was successfully treated with surgical management. Although surgical glue can be effectively used 
for hemostasis, it can induce delayed vascular complications. Therefore, surgical glue should be used 
cautiously.
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Case report
A 56-year-old woman was referred to the emer-
gency room (ER) because of an abrupt onset of chest 
pain, 8 hours before her presentation to the ER. 
Three months previously, she underwent aortic valve 
replacement and graft replacement of the ascending 
aorta at another hospital because of severe aortic re-
gurgitation with an ascending aortic aneurysm. Her 
medical history showed no evidence of connective 
tissue disease. A 12-lead electrocardiogram showed 
ST elevation in leads V4–V6. During her stay in the 
ER, cardiopulmonary resuscitation was done for 3 
minutes because of pulseless electrical activity. 
Coronary angiography (CAG) was performed to check 
for coronary artery disease; however, the findings 
were non-specific. She was referred to Gangnam 
Severance Hospital after CAG. Contrast-enhanced com-
puted tomography (CT) revealed extravasation of dye 
from the main pulmonary artery (MPA), suggesting 
rupture of the MPA, and a 77-mm hematoma around 
the ascending aorta (Fig. 1).
The patient underwent emergency surgery to re-
pair the pulmonary artery and to evacuate the 
hematoma. In the operative field, no active bleeding 
was found around the prosthetic ascending aorta 
graft; however, there was a 1.5-cm longitudinal tear 
on the MPA. Around the tearing site, the tissue was 
soft and friable, and brownish foreign material was 
densely adhered to the vessel. However, the other 
neighboring tissue was firm and did not show in-
flammation or necrotic changes, so the tear was re-
pairable without the use of other materials, such as 
pericardium or a Gore-Tex membrane (Fig. 2). After 
reviewing the medical records from the patient’s pre-
vious operation, we found that the brownish material 
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Fig. 1. (A, B) Chest computed tomography images showing a periaortic hematoma and contrast extravasation from the pulmonary artery.
Fig. 2. Intraoperative findings. (A) 
Perivascular necrosis around the 
main pulmonary artery (arrow). (B) 
Pulmonary artery after primary re-
pair (arrow). (C) Tissue debride-
ment (white arrow) with BioGlue 
(black arrow).
around the tearing site was BioGlue (CryoLife Inc., 
Kennesaw, GA, USA). After blocking back-flow with a 
Foley catheter in the MPA, the necrotic MPA tissue 
was resected and repaired with continuous 3-0 
Prolene sutures.
The patient was extubated on postoperative day 
14 and moved to the general ward on postoperative 
day 21. Her follow-up chest CT showed a patent and 
firm pulmonary artery, and she was discharged with-
out any other complications.
Discussion
BioGlue (CryoLife Inc.) is an adhesive solution ap-
proved in 1998 by the Food and Drug Administration 
for use in the United States for treating acute thora-
cic aortic dissections. It is composed of purified bo-
vine serum albumin (45%) and glutaraldehyde (10%). 
Glutaraldehyde serves as a bridge between albumin 
molecules and binds albumin to tissue proteins. Thus, 
this reaction forms a permanent covalent bond be-
tween the tissues and adhesive. Linkage starts within 
20–30 seconds, and the maximum bonding capability 
is reached in 3 minutes [1].
The use of biological glue has been reported to 
improve outcomes and reduce mortality from acute 
type A aortic dissections. Coselli et al. [2] reported 
that using BioGlue as an adjunct to repair aortic tis-
sue showed superior results in terms of anastomotic 
bleeding compared with the control group. No major 
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differences were observed in adverse events such as 
stroke, death, and transfusion.
However, recent reviews have raised concerns 
about the rate of reoperations because of aortic wall 
necrosis and redissection. In 2001, Kazui et al. [3] 
reported 4 cases (7%) of redissection after acute 
aortic dissection repair; these cases were retro-
gradely extended to the aortic annulus and required 
root reconstruction. Tissue necrosis was noted at the 
application site of the glue, and a histopathological 
evaluation revealed the disappearance of medial 
smooth muscle, suggesting tissue necrosis. In addi-
tion, Luk et al. [4] reported 2 cases of pseudoaneur-
ysm formation after BioGlue application. These cases 
also showed inflammatory reactions due to BioGlue 
itself on histopathology.
Polymerized BioGlue can still release glutaral-
dehyde, which is known to cause cytotoxic effects in 
the neighboring tissue, including aortic tissue, by in-
ducing inflammation, edema formation, and necrosis 
at the site of application [5].
Complications of BioGlue embolization include cor-
onary embolism, acute limb ischemia, cerebral embo-
lism, and pulmonary embolism [6,7]. Moreover, the 
spillage of BioGlue can lead to complications due to 
the creation of masses, reactive fluid collections, and 
compression of adjacent structures [7,8].
In this case, pulmonary artery rupture occurred as 
a result of a chemical reaction with BioGlue. Some 
amount of the BioGlue that had been applied to the 
aortic root spread to the neighboring pulmonary ar-
tery and seemingly induced an inflammatory reaction. 
Although there are also other possibilities for ex-
plaining the MPA injury, such as mechanical laceration 
by dense BioGlue material or necrosis due to peri-
aortic graft inflammation, the inflammatory changes 
were focal around the site where BioGlue was ap-
plied, and systemic inflammatory changes were not 
definitively present around the perigraft vessels. 
Therefore, a focal chemical reaction triggered by 
BioGlue is thought have been the main reason for 
the necrotic changes in the MPA.
Furthermore, the adhered material (hematoma with 
BioGlue) between the aortic conduit and MPA was 
thought to have caused direct pressure on the ne-
crotic portion of the MPA. Consequently, repetitive 
pressure on the necrotic MPA seemed to induce MPA 
tearing. Because the pulmonary artery is exposed to 
less pressure than the aorta, the patient was able to 
survive for 9 hours from symptom onset despite the 
rupture.
Thus, surgical glue should be carefully used, be-
cause it can induce delayed complications, such as 
native vessel necrosis, dissection, and embolization.
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